0001950047-24-003875.txt : 20240517 0001950047-24-003875.hdr.sgml : 20240517 20240517163157 ACCESSION NUMBER: 0001950047-24-003875 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240517 DATE AS OF CHANGE: 20240517 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 24960339 BUSINESS ADDRESS: STREET 1: 6027 EDGEWOOD BEND COURT CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Sharp Shalini CENTRAL INDEX KEY: 0001377202 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 144 1 primary_doc.xml 144 0001377202 XXXXXXXX LIVE 0000914475 NEUROCRINE BIOSCIENCES INC 000-22705 6027 Edgewood Bend Court San Diego CA 92130 8586177600 SHALINI SHARP Director COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

1106 156952.46 100637227 05/17/2024 NASDAQ Common 05/17/2024 Restricted Stock Units Issuer N 1106 05/17/2024 N/A Y 05/17/2024 11/27/2023 /s/ Shalini Sharp